COVID-19 Updates
From the Journals
Updates on treatment/prevention of VTE in cancer patients
“Because patients with cancer have a baseline increased risk of VTE, compared with patients without cancer, the combination of both COVID-19 and...
From the Journals
One in eight COVID patients likely to develop long COVID: Large study
“This finding shows that post–COVID-19 condition is an urgent problem with a mounting human toll.”
News from the FDA/CDC
Long COVID doubles risk of some serious outcomes in children, teens
“Many of these conditions were rare or uncommon among children in this analysis, but even a small increase in these conditions is notable.”
Latest News
Haven’t had COVID yet? Wanna bet?
These silent COVID-19 cases reflect a hidden side of the pandemic that may be helping to drive new surges and viral variants.
From the Journals
‘Striking’ disparities in CVD deaths persist across COVID waves
Black Americans have almost threefold higher rates of excess cardiovascular disease mortality than Whites, according to a national analysis of...
Feature
Scientists aim to combat COVID with a shot in the nose
The Biden administration held a summit on the future of COVID-19 vaccines.
From the Journals
Two distinct phenotypes of COVID-related myocarditis emerge
A new study points to significantly different clinical presentations, immunologic profiles, and outcomes.
From the Journals
Hypertension heightens risk for severe COVID-19, even in the fully vaxxed
Vaccinated and boosted adults with high blood pressure were more than twice likely to be hospitalized for COVID-19 than were those without...
From the Journals
Immune response may explain brain damage after COVID-19
Antibodies appear involved in an attack on the cells lining the brain’s blood vessels.
Latest News
Biden tests positive for COVID-19: White House
President Biden plans to isolate at the White House and “will continue to carry out all of his duties fully during that time.”
From the Journals
RV dysfunction slams survival in acute COVID, flu, pneumonia
The findings suggest that abnormal RV findings should be considered a mortality risk marker in patients with acute respiratory illness.